• Adare Acquires Egalet’s Parvulet Technology Platform contractpharma
    April 18, 2019
    Adare Pharmaceuticals has entered into an agreement with Egalet Corporation to acquire global rights of the Parvulet technology platform and its associated intellectual property (IP).
PharmaSources Customer Service